{
  "main_header": {
    "sid": 384463,
    "name": "Vista Pharma.",
    "stock_name": "Vista Pharma.",
    "full_name": "Vista Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/vista-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "8.14",
    "chg": 0.01,
    "chgp": "0.12%",
    "dir": 1,
    "prev_price": "8.13",
    "mcapval": "50.10 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524711,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE427C01021",
    "curr_date": "Dec 17",
    "curr_time": "",
    "bse_nse_vol": "8.65 k",
    "exc_status": "Active",
    "traded_date": "Dec 17, 2025",
    "traded_date_str": "2025 12 17",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/vista-pharma-384463-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Vista Pharma. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-vista-pharma-fallingrising-3756736",
        "imagepath": "",
        "date": "2025-12-12 00:44:42",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Extended Downtrend Evident in Price Movements</strong></p>\n<p>Vista Pharmaceuticals has been on a downward trajectory for some time, with the stock losing 6.79% over the past week compared to a marginal 0.52% decline in the Sensex. The divergence becomes more pronounced over longer periods, as the stock has fallen 14.47% in the last month while the Sensex gained 1.13%. Year-to-date, Vista Pharma’s losses have mounted to 31.24%, starkly contrasting with the Sensex’s 8.55% gain. Over the past year, the stock has declined by 31.36%, whereas the benchmark index has appreciated by 4.04%. Even over three and five years, Vista Pharma has lagged significantly, with losses of 1.46% and 39.60% respectively, while the Sensex surged 36.40% and 83.99% in the same periods.</p>\n<p><strong>Recent Trading Ac..."
      },
      {
        "title": "Vista Pharma. Sees Revision in Market Assessment Amid Challenging Financial Trends",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vista-pharma-downgraded-to-strong-sell-amid-deteriorating-fundamentals-and-bearish-technicals-3750096",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/VistaPharma_mojoScore_3750096.png",
        "date": "2025-12-07 10:10:21",
        "description": "Vista Pharma., a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting ongoing challenges in its financial and operational performance. The recent assessment highlights concerns across multiple parameters including quality, valuation, financial trends, and technical outlook, underscoring the stock's current position within a difficult market environment."
      },
      {
        "title": "Why is Vista Pharma. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-vista-pharma-fallingrising-3715985",
        "imagepath": "",
        "date": "2025-11-19 21:49:42",
        "description": "As of 19-Nov, Vista Pharmaceuticals Ltd is experiencing a price increase, currently at Rs 9.18, which represents a rise of 1.53 or 20.0%. Today, the stock has outperformed its sector by 19.93% and has shown a trend reversal after two consecutive days of decline. It opened with a significant gain of 9.54% and reached an intraday high of Rs 9.18. However, despite this positive movement, the stock has been trading lower than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, there has been a notable decrease in investor participation, with delivery volume falling by 25.71% compared to the 5-day average, indicating a potential concern regarding sustained interest in the stock.\n\nIn the broader market context, Vista Pharmaceuticals has underperformed compared to the Sensex over various periods, including a 3-year return of +19.22% against the Sensex's +38.15%. In the short term, the st..."
      },
      {
        "title": "Vista Pharmaceuticals Hits Upper Circuit Amidst Extraordinary Buying Interest",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vista-pharmaceuticals-hits-upper-circuit-amidst-unprecedented-buying-interest-3715279",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/VistaPharmaceut_only_buyers_3715279.png",
        "date": "2025-11-19 12:05:13",
        "description": "Vista Pharmaceuticals Ltd witnessed an exceptional surge in buying interest on 19 Nov 2025, hitting the upper circuit with only buy orders in the queue. The stock recorded a remarkable 20.00% gain in a single trading session, significantly outperforming the Sensex’s modest 0.33% rise, signalling a potential multi-day circuit scenario driven by extraordinary demand and absence of sellers."
      },
      {
        "title": "Why is Vista Pharma. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-vista-pharma-fallingrising-3712836",
        "imagepath": "",
        "date": "2025-11-18 21:47:08",
        "description": "As of 18-Nov, Vista Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at Rs. 8.00, which represents a decrease of Rs. 0.39 or 4.65%. The stock has hit a new 52-week low of Rs. 7.63 today and has underperformed its sector by 4.03%. It has been on a downward trend, losing 15.07% over the last two days. Additionally, the stock has shown poor performance over various time frames, with a year-to-date decline of 32.09% and a one-year drop of 33.88%. The stock is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Although there has been a significant increase in investor participation, with delivery volume rising by 2223.84% against the 5-day average, the overall sentiment remains negative.\n\nIn the broader market context, Vista Pharmaceuticals' performance has been notably worse than the benchmark Sensex, which has gained 0..."
      },
      {
        "title": "Vista Pharmaceuticals Falls to 52-Week Low of Rs.7.63 Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vista-pharmaceuticals-falls-to-52-week-low-amidst-continued-downtrend-3712184",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/VistaPharmaceut_priceRelatedfactors_3712184.png",
        "date": "2025-11-18 15:46:47",
        "description": "Vista Pharmaceuticals has reached a new 52-week low of Rs.7.63 today, marking a significant decline in its stock price amid ongoing downward momentum. The stock has underperformed its sector and broader market indices, reflecting persistent challenges in its financial performance and valuation metrics."
      },
      {
        "title": "Why is Vista Pharma. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-vista-pharma-fallingrising-3708170",
        "imagepath": "",
        "date": "2025-11-17 21:40:00",
        "description": "As of 17-Nov, Vista Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at Rs. 8.39, which reflects a decrease of Rs. 1.03 or 10.93%. The stock has hit a new 52-week low of Rs. 8 today and has underperformed its sector by 11.21%. Although it opened with a gain of 3.4% and reached an intraday high of Rs. 9.9, it also saw a significant drop to an intraday low of Rs. 8, indicating high volatility with an intraday fluctuation of 10.61%. The stock has consistently underperformed over various periods, showing a year-to-date decline of 28.78% and a one-year drop of 31.51%. Additionally, it is trading below all key moving averages, which suggests a bearish trend. The delivery volume has increased significantly, indicating rising investor participation, but this has not translated into positive price movement.\n\nBroader Market Context: In comparison to the benchmark Sensex, which has shown pos..."
      },
      {
        "title": "Vista Pharmaceuticals Hits New 52-Week Low at Rs. 8 Amid Market Struggles",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vista-pharmaceuticals-hits-new-52-week-low-at-rs-8-amid-market-struggles-3707026",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/VistaPharmaceut_priceRelatedfactors_3707026.png",
        "date": "2025-11-17 10:43:44",
        "description": "Vista Pharmaceuticals has reached a new 52-week low of Rs. 8, reflecting a significant decline in its stock performance. The company has faced a 28.49% drop over the past year, alongside ongoing financial challenges, including operating losses and a negative EBIT to Interest ratio, raising concerns about its market position."
      },
      {
        "title": "Vista Pharmaceuticals Q2 FY26: Mounting Losses Signal Deepening Operational Crisis",
        "link": "https://www.marketsmojo.com/news/result-analysis/vista-pharmaceuticals-q2-fy26-mounting-losses-signal-deepening-operational-crisis-3715887",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/VistaPharmaceut_quaterlyResult_3715887.png",
        "date": "2025-11-15 09:26:51",
        "description": "Vista Pharmaceuticals Ltd., a micro-cap pharmaceutical manufacturer with a market capitalisation of ₹56.00 crores, reported catastrophic results for Q2 FY26, with net losses widening dramatically to ₹2.59 crores—a sequential deterioration of 100.78% from Q1 FY26's loss of ₹1.29 crores and a staggering 166.99% worsening compared to Q2 FY25's loss of ₹0.97 crores. The company's operational performance has collapsed into crisis territory, with operating margins plunging to an alarming -235.62% in Q2 FY26 from -73.03% in the previous quarter."
      }
    ],
    "total": 5698,
    "sid": "384463",
    "stock_news_url": "https://www.marketsmojo.com/news/vista-pharmaceuticals-384463"
  },
  "announcements": [
    {
      "caption": "Un Audited Financials Results For The Quarter And Half Year Ended 30.09.2025",
      "datetime": "13-Nov-2025",
      "details": "Un audited Financials Results for the quarter and half year ended 30.09.2025",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Un Audited Financial Results For The Quarter And Half Year Ended 30.09.2025",
      "datetime": "13-Nov-2025",
      "details": "Un audited financial Results for the quarter and half year ended 30.09.2025",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for 1. Unaudited Financial Results For The Quarter Ended 30.09.2025. 2. Limited Review Report For Quarter Ended 30.09.2025. 3. Any Other Business With The Permission Of The Chair.",
      "datetime": "04-Nov-2025",
      "details": "Vista Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 inter alia to consider and approve 1. Unaudited financial results for the quarter ended 30.09.2025. 2. Limited Review Report for quarter ended 30.09.2025. 3. Any other business with the permission of the Chair.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Why is Vista Pharma. falling/rising?

2025-12-12 00:44:42

Extended Downtrend Evident in Price Movements

Vista Pharmaceuticals has been on a downward trajectory for some time, with the stock losing 6.79% over the past week compared to a marginal 0.52% decline in the Sensex. The divergence becomes more pronounced over longer periods, as the stock has fallen 14.47% in the last month while the Sensex gained 1.13%. Year-to-date, Vista Pharma’s losses have mounted to 31.24%, starkly contrasting with the Sensex’s 8.55% gain. Over the past year, the stock has declined by 31.36%, whereas the benchmark index has appreciated by 4.04%. Even over three and five years, Vista Pharma has lagged significantly, with losses of 1.46% and 39.60% respectively, while the Sensex surged 36.40% and 83.99% in the same periods.

Recent Trading Ac...

Read More

Vista Pharma. Sees Revision in Market Assessment Amid Challenging Financial Trends

2025-12-07 10:10:21

Vista Pharma., a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting ongoing challenges in its financial and operational performance. The recent assessment highlights concerns across multiple parameters including quality, valuation, financial trends, and technical outlook, underscoring the stock's current position within a difficult market environment.

Read More

Why is Vista Pharma. falling/rising?

2025-11-19 21:49:42

As of 19-Nov, Vista Pharmaceuticals Ltd is experiencing a price increase, currently at Rs 9.18, which represents a rise of 1.53 or 20.0%. Today, the stock has outperformed its sector by 19.93% and has shown a trend reversal after two consecutive days of decline. It opened with a significant gain of 9.54% and reached an intraday high of Rs 9.18. However, despite this positive movement, the stock has been trading lower than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, there has been a notable decrease in investor participation, with delivery volume falling by 25.71% compared to the 5-day average, indicating a potential concern regarding sustained interest in the stock. In the broader market context, Vista Pharmaceuticals has underperformed compared to the Sensex over various periods, including a 3-year return of +19.22% against the Sensex's +38.15%. In the short term, the st...

Read More

Vista Pharmaceuticals Hits Upper Circuit Amidst Extraordinary Buying Interest

2025-11-19 12:05:13

Vista Pharmaceuticals Ltd witnessed an exceptional surge in buying interest on 19 Nov 2025, hitting the upper circuit with only buy orders in the queue. The stock recorded a remarkable 20.00% gain in a single trading session, significantly outperforming the Sensex’s modest 0.33% rise, signalling a potential multi-day circuit scenario driven by extraordinary demand and absence of sellers.

Read More

Why is Vista Pharma. falling/rising?

2025-11-18 21:47:08

As of 18-Nov, Vista Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at Rs. 8.00, which represents a decrease of Rs. 0.39 or 4.65%. The stock has hit a new 52-week low of Rs. 7.63 today and has underperformed its sector by 4.03%. It has been on a downward trend, losing 15.07% over the last two days. Additionally, the stock has shown poor performance over various time frames, with a year-to-date decline of 32.09% and a one-year drop of 33.88%. The stock is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Although there has been a significant increase in investor participation, with delivery volume rising by 2223.84% against the 5-day average, the overall sentiment remains negative. In the broader market context, Vista Pharmaceuticals' performance has been notably worse than the benchmark Sensex, which has gained 0...

Read More

Vista Pharmaceuticals Falls to 52-Week Low of Rs.7.63 Amidst Continued Downtrend

2025-11-18 15:46:47

Vista Pharmaceuticals has reached a new 52-week low of Rs.7.63 today, marking a significant decline in its stock price amid ongoing downward momentum. The stock has underperformed its sector and broader market indices, reflecting persistent challenges in its financial performance and valuation metrics.

Read More

Why is Vista Pharma. falling/rising?

2025-11-17 21:40:00

As of 17-Nov, Vista Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at Rs. 8.39, which reflects a decrease of Rs. 1.03 or 10.93%. The stock has hit a new 52-week low of Rs. 8 today and has underperformed its sector by 11.21%. Although it opened with a gain of 3.4% and reached an intraday high of Rs. 9.9, it also saw a significant drop to an intraday low of Rs. 8, indicating high volatility with an intraday fluctuation of 10.61%. The stock has consistently underperformed over various periods, showing a year-to-date decline of 28.78% and a one-year drop of 31.51%. Additionally, it is trading below all key moving averages, which suggests a bearish trend. The delivery volume has increased significantly, indicating rising investor participation, but this has not translated into positive price movement. Broader Market Context: In comparison to the benchmark Sensex, which has shown pos...

Read More

Vista Pharmaceuticals Hits New 52-Week Low at Rs. 8 Amid Market Struggles

2025-11-17 10:43:44

Vista Pharmaceuticals has reached a new 52-week low of Rs. 8, reflecting a significant decline in its stock performance. The company has faced a 28.49% drop over the past year, alongside ongoing financial challenges, including operating losses and a negative EBIT to Interest ratio, raising concerns about its market position.

Read More

Vista Pharmaceuticals Q2 FY26: Mounting Losses Signal Deepening Operational Crisis

2025-11-15 09:26:51

Vista Pharmaceuticals Ltd., a micro-cap pharmaceutical manufacturer with a market capitalisation of ₹56.00 crores, reported catastrophic results for Q2 FY26, with net losses widening dramatically to ₹2.59 crores—a sequential deterioration of 100.78% from Q1 FY26's loss of ₹1.29 crores and a staggering 166.99% worsening compared to Q2 FY25's loss of ₹0.97 crores. The company's operational performance has collapsed into crisis territory, with operating margins plunging to an alarming -235.62% in Q2 FY26 from -73.03% in the previous quarter.

Read More

View All News